US Stock MarketDetailed Quotes
RNA Avidity Biosciences
- 43.330
- -0.470-1.07%
Close Nov 27 16:00 ET
- 43.340
- +0.010+0.02%
Post 20:01 ET
5.17BMarket Cap-15045P/E (TTM)
44.515High42.630Low730.13KVolume43.990Open43.800Pre Close31.64MTurnover0.79%Turnover RatioLossP/E (Static)119.31MShares56.00052wk High3.44P/B4.01BFloat Cap6.79052wk Low--Dividend TTM92.43MShs Float56.000Historical High--Div YieldTTM4.30%Amplitude4.825Historical Low43.330Avg Price1Lot Size
About Avidity Biosciences Company
Avidity Biosciences, Inc. engages in the development of a new class of oligonucleotide-based therapies called Antibody Oligonucleotide Conjugates (AOC). It utilizes its AOC platform to design, engineer, and develop therapeutics that combine the tissue selectivity of monoclonal antibodies and the precision of oligonucleotide-based therapies in order to access previously undruggable tissue and cell types and more effectively target underlying genetic drivers of diseases. The company was founded by Troy E. Wilson, Kent Hawryluk, Mark E. Davis, and Francis Patrick McCormick on November 13, 2012 and is headquartered in San Diego, CA.
Company Profile
SymbolRNA
Company NameAvidity Biosciences
Listing DateJun 12, 2020
Issue Price18.00
Founded2012
CEOMs. Sarah Boyce
MarketNASDAQ
Employees253
Fiscal Year Ends12-31
Address10578 Science Center Drive,Suite 125
CitySan Diego
ProvinceCalifornia
CountryUnited States of America
Zip Code92121
Phone1-858-401-7900
Company Executives
- Name
- Position
- Salary
- Sarah Boyce
- Director, President and Chief Executive Officer
- 11.14M
- Eric Mosbrooker
- Chief Strategy Officer
- 235.31K
- Dr. W. Michael Flanagan
- Chief Scientific and Technical Officer
- 4.89M
- Teresa McCarthy
- Chief Human Resources Officer
- 3.73M
- Michael F. Maclean
- Chief Financial Officer, Chief Business Officer and Principal Accounting Officer
- 4.48M
- Dr. Troy E. Wilson, PhD, J.D.
- Chairman of the Board
- 260.31K
- Dr. Arthur A. Levin,PhD
- Distinguished Scientist and Strategic Leader and Director
- 3.03M
- Jean Kim
- Independent Director
- 237.81K
- Dr. Edward M. Kaye, M.D.
- Independent Director
- 244.31K
- Carsten Boess
- Independent Director
- 245.31K
- Dr. Noreen Roth Henig, M.D.
- Independent Director
- 245.81K
- Simona Skerjanec, M.B.A.
- Independent Director
- --
- Tamar Thompson
- Independent Director
- 239.31K
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data